澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IMMURON LTD

0.033

+0.00310.00%

成交量：12.68萬

成交額：4,031.00

市值：1,077.96萬

市盈率：-1.43

高：0.033

開：0.029

低：0.029

收：0.030

52周最高：0.098

52周最低：0.026

股本：3.27億

流通股本：2.65億

量比：0.39

換手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-0.023

每股收益(LYR):-0.023

淨資產收益率：-39.68%

總資產收益率：-21.93%

市淨率：0.82

市盈率(LYR):-1.46

資料載入中...

總覽公司新聞資訊公告

IMMURON LTD作出戰略決策：尋求合作伙伴為Travelan與IMM-529臨床項目提供資金支持

Immuron宣佈IMM-529的IND獲得FDA批准

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IMC.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","market":"AU","secType":"STK","nameCN":"IMMURON LTD","latestPrice":0.033,"timestamp":1774501204664,"preClose":0.03,"halted":0,"volume":126835,"delay":0,"changeRate":0.10000000000000009,"nameEN":"IMMURON LTD","floatShares":265374293,"shares":326653609,"eps":-0.023,"marketStatus":"Pre CSPA","change":0.003,"latestTime":"03-26 16:06:24 AEDT","open":0.029,"high":0.033,"low":0.029,"amount":4031,"amplitude":0.133333,"askPrice":0.032,"askSize":463915,"bidPrice":0.028,"bidSize":80000,"shortable":3,"etf":0,"ttmEps":-0.023,"tradingStatus":3,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774566000000},"marketStatusCode":13,"adr":0,"exchange":"ASX","adjPreClose":0.03,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":0.393328,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMC.AU","preClose":0.03,"auctionPrice":0.03,"auctionVolume":4424,"auctionTime":1774501204664,"referencePrice":0.033,"referenceTime":1774501204664,"auction":3,"marketStatus":"盘后竞价","timestamp":1774501204664}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","floatShares":265374293,"roa":"-21.93%","roe":"-39.68%","lyrEps":-0.022586,"volumeRatio":0.393328,"shares":326653609,"dividePrice":0,"high":0.033,"amplitude":0.133333,"preClose":0.03,"low":0.029,"week52Low":0.026,"pbRate":"0.82","psRate":"1.44","week52High":0.098,"institutionHeld":0,"latestPrice":0.033,"committee":-0.705836,"eps":-0.023,"divideRate":0,"volume":126835,"delay":0,"ttmEps":-0.023,"open":0.029,"prevYearClose":0.036,"prevWeekClose":0.027,"prevMonthClose":0.028,"prevQuarterClose":0.036,"fiveDayClose":0.027,"twentyDayClose":0.029,"sixtyDayClose":0.038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-02-28","symbol":"IMC.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1677502800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMC.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138357123","title":"IMMURON LTD作出戰略決策：尋求合作伙伴為Travelan與IMM-529臨床項目提供資金支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1138357123","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138357123?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 19:12","pubTimestamp":1772017927,"startTime":"0","endTime":"0","summary":"IMMURON LTD宣布已制定关键战略方针，将通过寻求外部合作的方式为旗下两款核心产品——Travelan与IMM-529的临床研究计划注入资金动力。该决策旨在加速推进两项临床项目的研发进程，同时优化公司资源分配结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"1125337681","title":"Immuron宣佈IMM-529的IND獲得FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1125337681","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125337681?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:42","pubTimestamp":1763570545,"startTime":"0","endTime":"0","summary":"11月5日 - Immuron Ltd宣布，*IMM-529的IND已获得FDA批准*。进一步的公司报道：IMC.AX","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}